Immune Effector Cell-Associated HLH-Like Syndrome (IEC-HS) in CAR-T and TCE-Treated Myeloma and B-Cell Malignancies: Insights from a Pharmacovigilance Study
Year: 2025
Type: article
Language: en
Topic: Autoimmune and Inflammatory Disorders Research
Authors and affiliations:
raw_author_name: Sohaib Irfan
raw_affiliation_strings: Aga Khan University, Karachi, Pakistan. Electronic address: sohaibirfan910@gmail.com
Aga Khan University, Pakistan. Electronic address: sohaibirfan910@gmail.com
raw_author_name: Fathima Shehnaz Ayoobkhan
raw_affiliation_strings: Trinity Health Oakland/Wayne State University, Pontiac, Michigan
Trinity Health Oakland/ Wayne State University, Pontiac, MI
raw_author_name: Nikhil Vojjala
raw_affiliation_strings: Trinity Health Oakland/Wayne State University, Pontiac, Michigan
Trinity Health Oakland/ Wayne State University, Pontiac, MI
raw_author_name: Raabia Qureshi
raw_affiliation_strings: University of Missouri-Kansas City, Kansas City, Missouri
University of Missouri, Kansas City
raw_author_name: Raeef Rahman
raw_affiliation_strings: Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, Kansas
Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, KS
raw_author_name: Ishita Kamboj
raw_affiliation_strings: Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, Kansas; U.S. Myeloma Innovations Research Collaborative (USMIRC), Kansas City, Kansas State
Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, KS; U.S. Myeloma Innovations Research Collaborative (USMIRC)
raw_author_name: Al-Ola Abdallah
raw_affiliation_strings: Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, Kansas; U.S. Myeloma Innovations Research Collaborative (USMIRC), Kansas City, Kansas State
Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, KS; U.S. Myeloma Innovations Research Collaborative (USMIRC)
raw_author_name: Joseph McGuirk
raw_affiliation_strings: Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, Kansas
Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, KS
raw_author_name: Zahra Mahmoudjafari
raw_affiliation_strings: Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, Kansas
Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, KS
raw_author_name: Forat Lutfi
raw_affiliation_strings: Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, Kansas
Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, KS
raw_author_name: Nausheen Ahmed
raw_affiliation_strings: Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, Kansas
Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, KS